The actinomycete Nonomuraea sp. strain ATCC 39727 produces the glycopeptide A40926, the precursor of dalbavancin. Biosynthesis of A40926 is encoded by the dbv gene cluster, which contains 37 protein-coding sequences that participate in antibiotic biosynthesis, regulation, immunity, and export. In addition to the positive regulatory protein Dbv4, the A40926-biosynthetic gene cluster encodes two additional putative regulators, Dbv3 and Dbv6. Independent mutations in these genes, combined with bioassays and liquid chromatography-mass spectrometry (LC-MS) analyses, demonstrated that Dbv3 and Dbv4 are both required for antibiotic production, while inactivation of dbv6 had no effect. In addition, overexpression of dbv3 led to higher levels of A40926 production. Transcriptional and quantitative reverse transcription (RT)-PCR analyses showed that Dbv4 is essential for the transcription of two operons, dbv14-dbv8 and dbv30-dbv35, while Dbv3 positively controls the expression of four monocistronic transcription units (dbv4, dbv29, dbv36, and dbv37) and of six operons (dbv2-dbv1, dbv14-dbv8, dbv17-dbv15, dbv21-dbv20, dbv24-dbv28, and dbv30-dbv35). We propose a complex and coordinated model of regulation in which Dbv3 directly or indirectly activates transcription of dbv4 and controls biosynthesis of 4-hydroxyphenylglycine and the heptapeptide backbone, A40926 export, and some tailoring reactions (mannosylation and hexose oxidation), while Dbv4 directly regulates biosynthesis of 3,5-dihydroxyphenylglycine and other tailoring reactions, including the four cross-links, halogenation, glycosylation, and acylation.
T he glycopeptide antibiotic A40926 (Fig. 1A) is the precursor for dalbavancin, a semisynthetic lipoglycopeptide approved for clinical use in 2014 by the U.S. Food and Drug Administration to treat acute bacterial skin and skin structure infections caused by bacteria, such as Staphylococcus aureus (methicillin-susceptible and methicillin-resistant strains) and Streptococcus pyogenes. Compared with the structurally related glycopeptide teicoplanin, dalbavancin possesses better potency and pharmacokinetic properties.
A40926 is produced by the actinomycete Nonomuraea sp. strain ATCC 39727 as a complex of related compounds. It consists of a heptapeptide containing the proteinogenic amino acid tyrosine and the nonproteinogenic amino acids 3,5-dihydroxyphenylglycine (DPG) and 4-hydroxyphenylglycine (HPG) (1) (2) (3) (4) . The heptapeptide is assembled by a nonribosomal peptide synthetase (NRPS) and then modified by oxidative cross-linking of the aromatic side chains to yield a rigid peptide scaffold. Further tailoring steps include halogenation, glycosylation, oxidation, methylation, acetylation, and acylation (5) . The A40926 components differ by the type of N-acyl chain attached to the glucuronic acid moiety and by the presence or absence of an O-linked acetyl residue at position 6 of the mannose (6) (7) (8) . The form with the acetylated mannose was proposed to be the final biosynthetic product, which in turn exerts an inhibitory effect on A40926 production by a yet unknown mechanism (8) . Detailed studies of A40926 biosynthesis and its regulation will be crucial for the development of rational approaches towards overproduction of the dalbavancin precursor.
The dbv gene cluster for A40926 biosynthesis contains 37 protein-coding sequences (Fig. 1B) that participate in antibiotic biosynthesis, regulation, immunity, and export (5) . Previous reverse transcription (RT)-PCR analysis of the intergenic regions (9) revealed that the cluster contains five monocistronic transcription units (dbv3, dbv4, dbv29, dbv36, and dbv37) and nine operons (dbv2-dbv1, dbv5-dbv7, dbv14-dbv8, dbv17-dbv15, dbv18-dbv19, dbv20-dbv21, dbv22-dbv23, dbv24-dbv28, and dbv30-dbv35), indicated by arrows in Fig. 1B .
The cluster contains the positive regulatory gene dbv4, the putative regulatory gene dbv3, and the two-component system-encoding genes dbv6-dbv22 (5) . Most glycopeptide gene clusters encode a homolog of Dbv4, as well as conserved Dbv4-binding sites (10) (11) (12) . Indeed, our previous analysis revealed that Dbv4 is a DNA-binding protein that acts as a positive regulator of A40926 biosynthesis by controlling expression of just two dbv operons: dbv14-dbv8, encoding the four cross-linking oxygenases, the halogenase, the N-acetylglucosamine transferase, and the N-acylase, and dbv30-dbv35, encoding the four enzymes involved in DPG biosynthesis, as well as the sodium-proton antiporter and a protein of unknown function (9) . In previous work, we also showed that expression of dbv4 is increased under phosphate-limiting conditions (9) .
The putative regulator Dbv3 belongs to the LAL (large ATPbinding regulators of LuxR) family. Recently, several regulators of the LAL family have been identified in antibiotic and other secondary-metabolite gene clusters from actinomycetes (13) (14) (15) (16) . The last two positive regulators, dbv6 and dbv22, encode a response regulator and a histidine sensory kinase, respectively, homologous to the Streptomyces lividans CutR/CutS pair that negatively regulates secondary metabolism (17) . In this study, we characterize the functions of dbv3, dbv4, and dbv6 in regulating A40926 biosynthesis in Nonomuraea sp. strain ATCC 39727 and demonstrate that most of the dbv genes are under the control of Dbv3.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Escherichia coli strains were grown in Luria broth liquid medium at 37°C and were supplemented with 50 g ml Ϫ1 apramycin when necessary to maintain plasmids. Frozen cell stocks of Nonomuraea strains were prepared by storing individual aliquots of the desired strain from midexponential cultures in R3 medium [10 g/liter glucose, 5 g/liter yeast extract, 0.1 g/liter Casamino Acids, 3 g/liter L-proline, 10 g/liter MgCl 2 · 6H 2 O, 4 g/liter CaCl 2 · 2H 2 O, 0.2 g/liter K 2 SO 4 , 0.05 g/liter KH 2 PO 4 , 5.6 g/liter N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), 2 ml/liter trace elements, pH 7.2] at Ϫ80°C. Liquid cultures of Nonomuraea strains were prepared by inoculating 0.2 ml of the frozen cell stock into 20 ml of fresh R3 medium; after 120 h of growth, 1 ml of this culture was inoculated into 50 ml of fresh R3 medium in an orbital shaker (500 ϫ g) in 250-ml baffled flasks at 30°C. The cultivation media were supplemented with 50 g ml Ϫ1 apramycin to select for strains carrying integrated antibiotic resistance genes. For solid media, R3 was supplemented with 1.8% agar. To detect glycopeptide production, Nonomuraea strains were incubated in R3 liquid medium without apramycin, and aliquots of spent media or culture broths of the strains at different time points were withdrawn for analysis and stored at Ϫ80°C. To study the effect of dbv3 expression in the dbv3-overexpressing (Oedbv3) strain, Nonomuraea sp. strain ATCC 39727 and the Oe-dbv3 strain were grown in R3 liquid medium with 10 Ϫ8 M thiostrepton. This concentration was found to have no effect on Nonomuraea sp. strain ATCC 39727 growth and dbv3 transcription, and it did not inhibit Micrococcus luteus ATCC 9341 (18) and thus did not interfere with the assay of antibiotic activity due to A40926.
Analysis of antibiotic production. A paper disc diffusion method was used with M. luteus as the assay organism as described previously (19) . Nonomuraea strains were grown in selected liquid media under the conditions specified above. After cultivation, 100 l of spent medium was applied to Whatman 3 MM Chr paper discs (Whatman, Maidstone, United Kingdom). The wet discs were placed on the surface of LB soft agar inoculated with 100 l of M. luteus (optical density at 600 nm [OD 600 ] ϭ 1.2), and inhibition zones were measured after overnight incubation at 37°C. In parallel bioassays, the specific competitor D-Ala-D-Ala (20 g/ l) was added to the spent medium of broth cultures to confirm A40926 antibacterial activity. For high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analyses, 50 l of broth cultures was collected at the time points indicated and mixed briefly with 2 volumes of methanol followed by 1 h of incubation at 40°C. After centrifugation to remove the cells, the supernatant was lyophilized and redissolved in 100 l 10% dimethyl sulfoxide (DMSO). HPLC analyses were performed using an LC 2010A-HT (Shimadzu) equipped with a Merck LiChrosphere (5-m; 4.6-mm by 100-mm) C 18 column. Elution was performed at 1 ml min Ϫ1 at 50°C with a linear gradient from 10% to 90% phase B in 30 min. Phase A was 0.1% (vol/vol) trifluoroacetic acid (TFA) in H 2 O, and phase B was CH 3 CN. UV detection was set at 230 nm. LC-electrospray ionization (ESI)-MS data were recorded on an Ion Trap equipped with an LC Agilent 1100, using an Ascentis express Supelco RP18, 2.7-m (50-by 4.6-mm) column kept at 40°C, eluting at 1 ml DNA manipulation. Standard genetic techniques with E. coli and in vitro DNA manipulations were performed as described previously (20) . Isolation of Streptomyces total DNA was performed by the salting-out procedure (21) . Southern hybridization was carried out with probes labeled with digoxigenin by using the DIG DNA labeling kit (Roche Biochemicals). PstI-or PvuII (Invitrogen)-digested pIJ8600 was used as a probe. Chromosomal DNAs were digested with BamHI and PstI (Invitrogen). Construction of the ⌬dbv3, ⌬dbv4, ⌬dbv6, and Oe-dbv3 strains. dbv3, dbv4, and dbv6 of Nonomuraea sp. strain ATCC 39727 were deleted by replacing the gene with a cassette containing an apramycin-selectable marker using PCR targeting (22) . pIJ773 containing the apramycin resistance gene [aac(3)IV] and the oriT replication origin was used as a template. The PCR primers used to amplify the resistance cassette for deletion of the dbv genes are reported in Table S1 in the supplemental material. E. coli BW25113/pIJ790 bearing cosmid 11A5 (5) was electrotransformed with the deletion cassettes. The isolated mutant cosmids were first introduced into the nonmethylating E. coli strain ET12567 containing pUZ8002 and then transferred to Nonomuraea sp. strain ATCC 39727 by intergeneric conjugation. Briefly, Nonomuraea sp. strain ATCC 39727 was grown in 30 ml R3 medium in a 250-ml baffled flask and incubated at 30°C on a rotary shaker at 200 rpm for 40 h. Mycelium was collected, washed twice with ice-cold 10% (vol/vol) glycerol, and suspended in 10 ml of 10% (vol/vol) glycerol. Then, 0.5 ml of the mycelium was added to 0.5 ml E. coli donor cells prepared as described previously (21) . The mixtures were plated out on R3 agar plates. The conjugation plates were incubated for 18 to 20 h at 30°C and then overlaid with 1 ml water containing 1 mg nalidixic acid and 1 mg apramycin. The plates were incubated at 30°C for 10 to 15 days. Exconjugants were picked off and analyzed by PCR (data not shown), using primers reported in Table S1 in the supplemental material. One clone (out of 3 analyzed) contained the interrupted dbv3 gene, 3 clones (out of 12 analyzed) contained the interrupted dbv4 gene, and 1 clone (out of 9) carried the interrupted dbv6 gene. The fidelity of the PCR products was confirmed by sequencing (BMR Genomics).
To construct the Oe-dbv3 strain, a PCR fragment prepared using the primers dbv3 over for and dbv3 over rev (see Table S1 in the supplemental material) was cloned into pGEM T-Easy (Promega), digested with BglII (Invitrogen) and NdeI (Invitrogen), and then inserted between the BamHI (Invitrogen) and NdeI (Invitrogen) sites of pIJ8600 (21) under the control of the thiostrepton-inducible tipA promoter. Cloning was confirmed by sequencing the insert. The plasmid was transferred into Nonomuraea sp. strain ATCC 39727 by conjugation from E. coli ET12567 (pUZ8002) as described above, generating a strain called Oe-dbv3. As a control, pIJ8600 was inserted into the Nonomuraea sp. strain ATCC 39727 chromosome. Southern hybridization using PstI-digested pIJ8600 as a probe was carried out (see Fig. S1 in the supplemental material). As expected for integration at the chromosomal attB site, hybridizing bands of about 4.3 and 3.9 kb were observed with BamHI-digested chromosomal DNA (see Fig. S1 , lane 1, in the supplemental material) and four bands of about 6, 4.3, 2, and 0.8 kb (see Fig. S2 , lane 2, in the supplemental material) were observed with PstI-digested chromosomal DNA. No hybridization signal was detected for the parental strain (see Fig. S1 , lanes 3 and 4, in the supplemental material).
Total RNA isolation and qRT-PCR analysis. To perform transcriptional analysis of selected genes, mycelium was harvested from 6 ml of culture, resuspended in 1 ml P buffer (21) containing lysozyme (50 mg/ ml), and then incubated for 20 min at 37°C. RNA was extracted by using the RNeasy midi kit (Qiagen) according to the manufacturer's instructions. DNase I (Roche) treatment was performed at 37°C for 1 h, and RNA was precipitated with 2 volumes of ethanol in the presence of 0.1 volume of 3 M sodium acetate. After a washing step with 70% (vol/vol) ethanol and drying in air, the RNA pellet was resuspended in water. As a control for RNA quality, an RT-PCR with 0.1 g of total RNA and primer pairs internal to hrdB, encoding a vegetative sigma factor, was carried out using the Superscript One-Step RT-PCR kit (Invitrogen) under the conditions indicated by the supplier. PCRs using the same primers were performed on 0.5 g of RNA samples using 40 cycles to exclude the presence of genomic DNA. For quantitative RT (qRT)-PCR, a two-step protocol was used. The High-Capacity cDNA Archive kit (Applied Biosystems) was used to retrotranscribe 2 g of total extracted RNA in a total volume of 100 l. Primer pairs for the genes analyzed by qRT-PCR were designed with Primer3web version 4.0.0 (http://bioinfo.ut.ee/primer3/) to fulfill the following criteria: length, 20 Ϯ 2 bp; melting temperature (T m ), 60 Ϯ 1°C; GC content, Ͼ50%; and amplicon lengths ranging from 200 to 500 bp (see Table S1 in the supplemental material). Primer specificity was controlled by BLAST analysis. The PCR efficiency was estimated by using a free Web-based service (http://srvgen.upct.es/efficiency.html) (23) . Gene expression was analyzed quantitatively by using the Applied Biosystems 7300 real-time PCR system (Applied Biosystems) with SYBR green PCR master mix (Applied Biosystems) in 96-well plates. Two microliters of cDNA was added to 20 l of PCR mixture. Amplification required activation of AmpErase UNG at 50°C for 2 min, followed by denaturation at 95°C for 10 min and then 40 cycles at 95°C for 15 s and 60°C for 1 min. Melting curves were performed from 60 to 98°C to validate the specificity of the PCR. Three independent measurements were performed for each gene. The threshold cycle (C T ) values were determined with the baseline set automatically. The results were analyzed using the comparative critical threshold (⌬⌬C T ) method, in which the amount of target RNA is adjusted to an internal reference (24) . hrdB, encoding a vegetative sigma factor, and a 16S rRNA gene did not show significant expression variation, as revealed by absolute quantitative RT-PCR using RNA extracted after 24, 48, and 72 h from Nonomuraea sp. strain ATCC 39727 (see Fig. S2 in the supplemental material). Standard deviations were calculated from three independent experiments. The values were calculated using a standard curve obtained by measuring the fluorescence of known amounts (10, 100, 1,000, and 10,000 g) of cDNA and were used as internal references to normalize the results. Two different sets of experiments were carried out using one of the endogenous genes; the relative transcription values were compared and reported as the average of these two sets of experiments. Expression ratios were expressed as 2⌬⌬C T . Each run included negative controls.
RESULTS

Transcript abundance of regulatory genes during growth.
We evaluated the transcript levels of three regulatory genes present in the dbv cluster, dbv3, dbv4, and dbv6, during growth and in respect to A40926 production. Nonomuraea sp. strain ATCC 39727 growth and A40926 production were monitored in R3 liquid medium for 96 h. Microbiological bioassays indicated that A40926 biosynthesis was detectable after 60 h of growth ( Fig. 2A) . Total RNA was extracted before (at 24 and 48 h) and during (at 72 h) production and was analyzed for gene expression by qRT-PCR (Fig. 2B) using hrdB, encoding a vegetative sigma factor, as a control. The transcript levels for dbv3, dbv4, and dbv6 were ϳ5-, ϳ20, and ϳ3-fold higher, respectively, at 48 and 72 h than at 24 h, indicating that transcription of all the regulatory genes is upregulated and largely precedes the detection of A40926 in the medium (Fig. 2) . The largest increase was observed for dbv4.
Effects of inactivation of the dbv regulatory genes. Disruption of dbv3, dbv4, or dbv6 did not significantly alter the growth kinetics or the morphology of the mutants on the different media used (data not shown), indicating that these genes are not critical for bacterial growth and differentiation under the conditions used. In contrast, bioassays showed that inactivation of dbv3 and dbv4 abolished A40926 biosynthesis, while the absence of dbv6 did not have a measurable effect on production (Fig. 3A) . HPLC analysis confirmed that the ⌬dbv4 and ⌬dbv3 mutants produced undetectable levels of precursors and/or final product. In contrast, the metabolite profile of the ⌬dbv6 mutant was indistinguishable from that of Nonomuraea sp. strain ATCC 39727 (data not shown). These results indicate that both Dbv3 and Dbv4 are nec-essary for antibiotic production, whereas Dbv6 is not. Since Dbv6 did not show a role in antibiotic biosynthesis, we further characterized only the ⌬dbv3 and ⌬dbv4 strains.
Interplay between the regulators. In order to establish any hierarchical control, qRT-PCR of the dbv regulatory genes was performed in the ⌬dbv3 and ⌬dbv4 mutant strains. In the ⌬dbv4 strain, dbv3 and dbv6 were transcribed as in the parental strain (Fig. 4) , indicating that their expression is not strictly dependent and dbv6 in the ⌬dbv3 mutant after 60 h of growth. The transcription levels in the mutants were compared to those of the parental strain, taken as 1.0. The standard deviations (indicated by error bars) were calculated from three independent determinations of mRNA abundance in each sample. hrdB was used as an endogenous control. on Dbv4. In contrast, qRT-PCR analysis of the ⌬dbv3 strain revealed that dbv4 transcription was 10-fold reduced with respect to the parental strain, while dbv6 transcription was not changed significantly (Fig. 4) . These results suggest that Dbv3 controls dbv4 transcription but does not have a major role, if any, in regulating dbv6 transcription.
Dbv4 was previously shown to bind to the upstream regions of dbv14 and dbv30 (9) . Consistently, transcription of these two genes was strongly reduced in the ⌬dbv4 mutant (data not shown), indicating that Dbv4 is essential for transcription of dbv14 and dbv30 and, presumably, of the dbv14-dbv8 and dbv30-dbv35 operons (Fig. 1B) .
Identification of Dbv3 target genes. To identify Dbv3 target genes, total RNA was extracted from Nonomuraea sp. strain ATCC 39727 and the ⌬dbv3 strain, grown in R3 medium for 60 h, when antibiotic becomes detectable in the parental strain, and expression of dbv genes was analyzed by qRT-PCR. We concentrated on a subset of dbv genes, selecting them on the basis of transcriptional organization (Fig. 1B) : the two monocistronic genes dbv4 and dbv29 and dbv1, dbv6, dbv14, dbv15, dbv20, and dbv32 as representatives of the dbv1-dbv2, dbv5-dbv7, dbv14-dbv8, dbv17-dbv15, dbv20-dbv21, and dbv30-dbv35 operons, respectively (Fig. 1B) . The results clearly demonstrated that dbv1, dbv4, dbv14, dbv15, dbv20, dbv29, and dbv32 either are not transcribed or are 10-fold less transcribed in the ⌬dbv3 strain than in the parental strain (Fig. 5) . In contrast, dbv6 transcript levels in the ⌬dbv3 strain were similar to those in the parental strain, indicating again that Dbv3 does not control dbv6 transcription.
Increasing A40926 production by overexpression of dbv3. A dbv3-overexpressing strain (Oe-dbv3) was constructed by placing dbv3 under the control of the thiostrepton-inducible tipA promoter and integrating the construct at the chromosomal attB site (see Fig. S1 in the supplemental material). In agreement with the results obtained with the ⌬dbv3 mutant, no differences were observed between growth of the parental and Oe-dbv3 strains in liquid R3 medium (data not shown). To evaluate the effect of dbv3 overexpression on A40926 production, bioassays were performed using spent culture medium collected at different time points. The Oe-dbv3 strain produced more A40926 than the parental strain (Fig. 3B) . HPLC and LC-MS analyses confirmed that the Oe-dbv3 strain produced 1.7-to 2.2-fold more A40926 than the parental strain (Fig. 6A). (The control strain, containing a copy of the empty vector, showed production profiles similar to those of the parental strain, thus excluding an effect of pIJ8600 integration on antibiotic production [data not shown].)
Transcriptional control of A40926 production by Dbv3. To study the influence of Dbv3 on transcription of a subset of 20 dbv genes, RNA was extracted from Nonomuraea sp. strain ATCC 39727 and from the Oe-dbv3 mutant grown in the presence of 10 Ϫ8 M thiostrepton for 60 h and analyzed by qRT-PCR. With the exception of dbv19; the three cotranscribed genes dbv5, dbv6, and dbv7; and perhaps dbv23, the expression of all of the analyzed genes was significantly enhanced in the Oe-dbv3 strain compared with the parental strain (Fig. 6B) , with enhancement levels ranging from 2-fold (e.g., dbv1, dbv25, and dbv28) to 12-fold (dbv15 and dbv17). Thus, from the established operon structure of the dbv gene cluster (Fig. 1B) , we infer that Dbv3 may act as a positive regulator of 29 out of 37 dbv genes: those belonging to the six operons (dbv2-dbv1, dbv14-dbv8, dbv17-dbv15, dbv21-dbv20, dbv24-dbv28, and dbv30-dbv35) and the four monocistronic transcription units dbv4, dbv29, dbv36, and dbv37.
DISCUSSION
The present study was designed to elucidate the regulatory network for A40926 biosynthesis in the actinomycete Nonomuraea sp. strain ATCC 39727. Our experiments demonstrated that the transcriptional activators Dbv3 and Dbv4 are both required for A40926 biosynthesis, while Dbv6 does not influence A40926 biosynthesis (Fig. 3) .
Disruption of any of these regulators did not significantly alter growth in Nonomuraea sp. strain ATCC 39727. This is in accordance with recent work showing that inactivation of tei15* (dbv4-like) or tei16* (dbv3-like) in Actinoplanes teichomyceticus does not influence growth but leads to a complete block of teicoplanin production (12) .
qRT-PCR analysis showed that, in the absence of dbv4, transcription of dbv3 and dbv6 is not affected (Fig. 4) , whereas transcription of the dbv14-dbv8 and dbv30-dbv35 operons is (data not shown), confirming that Dbv4 acts as a positive pathway-specific regulator of A40926 biosynthesis. Moreover, dbv4, dbv14-dbv8, and dbv30-dbv35 transcription was previously demonstrated to be activated by phosphate limitation, and mobility shift assays demonstrated that a recombinant His-Dbv4 binds to a consensus sequence present upstream of dbv14 and dbv30 (9) . Similarly to Tei15* (12) from the teicoplanin gene cluster and differently from Bbr (11) and StrR (25) from the balhimycin-and streptomycinbiosynthetic gene clusters, respectively, Dbv4 was reported previously not to control its own expression (9) .
Expanding on previous results, we demonstrate that dbv4 transcription is controlled by Dbv3, a regulator belonging to the LAL protein family. We found that Dbv3 plays a positive role in A40926 production, since the ⌬dbv3 strain completely lost the ability to produce the antibiotic (Fig. 3) and transcription of dbv4 and of many other dbv genes was drastically inhibited (Fig. 5) . Several members of the LAL family are pathway-specific transcriptional activators of secondary-metabolite gene clusters in a range of actinomycetes (13, 14, (26) (27) (28) (29) (30) (31) (32) . Recently, two LAL proteins were identified as pleiotropic regulators affecting various cellular processes in Streptomyces coelicolor (15) . Improvement of A40926 production by Nonomuraea sp. strain ATCC 39727 has been successfully obtained using different growth conditions (33) (34) (35) (36) . One example of successful genetic manipulation has also been reported, since deletion of dbv23, responsible for adding the acetyl group to the mannose moiety, led to a 2-fold increase in A40926 yield (8) . In our studies, overexpression of dbv3 also resulted in higher antibiotic production, providing a potentially useful example of knowledge-based strain improvement.
Taken together, our results demonstrate that both Dbv3 and Dbv4 act as pathway-specific activators of A40926 biosynthesis, with Dbv3 hierarchically controlling dbv4 transcription. Our data suggest a cascade-like regulatory mechanism (Fig. 7) in which Dbv3 triggers transcription of dbv4 and, as a consequence, positively controls DPG biosynthesis and some key reactions that are the hallmark of glycopeptides (the four cross-links, halogenation, glycosylation, and acylation); in addition, Dbv3 controls HPG biosynthesis and heptapeptide backbone biosynthesis, as well as other tailoring reactions (mannosylation and hexose oxidation) and A40926 export. To our knowledge, the transcriptional activa- tion of the NRPS genes by Dbv3 (Fig. 6B) represents the first example of a LAL regulator positively controlling the expression of NRPS genes, while a few examples of LAL regulators acting on polyketide synthase (PKS) gene expression have been reported (14) .
Dbv4 and Dbv3 appear to be controlled by different stimuli, i.e., dbv4 transcription and the two Dbv4-controlled biosynthetic steps were demonstrated to be negatively regulated by phosphate, while the Dbv3-controlled genes were not (9) . Surprisingly, while the intergenic regions preceding Dbv4-controlled genes are highly conserved (9, 10), we could not identify any conserved sequences that could be the target of Dbv3, nor has a binding site for Tei16* been reported (12) . Thus, it remains to be determined whether Dbv3 exerts its influence by direct binding to regulatory regions or if other mechanisms are involved. The absence of conserved DNA sequences in all of the dbv genes whose transcript levels are higher after dbv3 overexpression suggests that Dbv3 control of A40926 biosynthesis might be indirect.
The dbv cluster was reported to have a mosaic structure (10) in which the various subclusters, responsible for different functional portions of the pathway, originated from different sources. Remarkably, the highly conserved Dbv4 regulator controls the expression of two operons devoted to important checkpoints along the A40926-biosynthetic pathway: one for synthesis of the specialized precursor DPG and the other for cross-linking, halogenation, and N-acetylglucosamine addition and acylation. The latter set of reactions contribute to the characteristic features of glycopeptides (multiple cross-links of the aromatic residues) and of the teicoplanin family in particular (acylated glucosamine attached to amino acid 4). It should also be noted that the P450 mono-oxygenases act during heptapeptide synthesis (37) , and thus, lack of expression of the dbv14-dbv8 operon, in which the mono-oxygenase genes reside, is likely to result in truncated peptides devoid of antibacterial activity, as seen with balhimycin (38) .
When comparing transcriptional regulation in different glycopeptide gene clusters, it is striking that the StrR-like regulators Dbv4, Bbr, and Tei15* all control one common biosynthetic step, DPG biosynthesis. However, beyond this common step, different clusters seem to have devised different regulatory strategies to control glycopeptide production: a single StrR-like regulator for balhimycin production, a StrR-like regulator controlling a LAL regulator in teicoplanin biosynthesis, and a LAL regulator controlling a StrR-like regulator for A40926 production. Our results not only enlarge our knowledge of the regulatory mechanisms used to control glycopeptide biosynthesis but also provide a basis for rational approaches for the generation of overproducers of the dalbavancin precursor.
